Keyphrases
Crohn's Colitis
100%
Bile Acids
100%
Farnesoid X Receptor
100%
Pharmacological Activation
100%
Fibroblast Growth Factor 19 (FGF19)
45%
Disease Control
36%
Chenodeoxycholic Acid
36%
Receptor Targets
27%
Gallbladder Volume
27%
Target Gene Expression
27%
Crohn's Disease
18%
Receptor Activation
18%
Serum Levels
9%
Inflammation
9%
Patient-controlled
9%
Gallbladder
9%
Murine Model
9%
Ultrasound
9%
Acid Activation
9%
Fasted State
9%
Ligand-receptor Binding
9%
Nuclear Receptor
9%
Anti-inflammatory Properties
9%
Bacterial Overgrowth
9%
Intestinal Barrier Integrity
9%
Mouse Colitis
9%
INIS
patients
100%
receptors
100%
bile acids
100%
control
41%
diseases
33%
gallbladder
33%
levels
25%
volume
25%
genes
25%
doses
16%
inflammation
16%
data
8%
biopsy
8%
comparative evaluations
8%
barriers
8%
fasting
8%
ligands
8%
growth factors
8%
fibroblasts
8%
Medicine and Dentistry
Granulomatous Colitis
100%
Bile Acid
100%
Farnesoid X Receptor
100%
Fibroblast Growth Factor 19
45%
Disease
36%
Chenodeoxycholic Acid
36%
Gene Expression
27%
Colitis
9%
Intestinal Mucosal Barrier
9%
Anti-Inflammatory Drug
9%
Cell Nucleus Receptor
9%
Bacterial Overgrowth
9%
Biopsy Technique
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Colitis
100%
Farnesoid X Receptor
100%
Fibroblast Growth Factor 19
45%
Disease
36%
Chenodeoxycholic Acid
36%
Inflammation
9%
Murine
9%
Anti-Inflammatory Drug
9%
Receptor Agonist
9%
Cell Nucleus Receptor
9%